RedHill Biopharma (RDHL) Preferred Stock Liabilities (2012)
RedHill Biopharma (RDHL) reported Preferred Stock Liabilities of $8.0 million for Q4 2012.
RedHill Biopharma (RDHL) Preferred Stock Liabilities (2012) Analysis & Trends
RedHill Biopharma (RDHL) has 1 years of Preferred Stock Liabilities data on file, last reported at $8.0 million in Q4 2012.
- Preferred Stock Liabilities for Q4 2012 came in at $8.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2012 was $8.0 million (changed N/A YoY), and the FY2012 annual result was $8.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities was little changed at $8.0 million in Q4 2012 per RDHL's latest filing.
- Over five years, Preferred Stock Liabilities peaked at $8.0 million in Q4 2012 and troughed at $8.0 million in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | RedHill Biopharma | 119.32 Mn | 119.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 8.02 Mn |